| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 84,000 | $1 | $336K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 8,430 | $30 | $286.4K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 9,100 | $30 | $236.6K |
| J3262 | Injection, tocilizumab, 1 mg | 30,330 | $10 | $151.6K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 11,150 | $10 | $111.5K |
| J0897 | Injection, denosumab, 1 mg | 4,260 | $20 | $76.7K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 310 | $110 | $33.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 300 | $100 | $29.1K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 410 | $60 | $24.4K |
| J1201 | Injection, cetirizine hydrochloride, 0.5 mg | 1,200 | $10 | $14.4K |